Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

Fig. 2

a Maximum platelet aggregation responses assessed by light transmittance aggregometry. AA arachidonic acid; b proportions of participants during each treatment period with high (HRPR) and low residual platelet reactivity (LRPR), defined as a maximum aggregation response to 20 μmol/L ADP of > 59% and ≤ 59% respectively

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840